Issue 6/2013

Biological effects of four frequently used medicinal plants of Lamiaceae (585 — 597)

A. SRANCIKOVA, E. HORVATHOVA, K. KOZICS

DOI: 10.4149/neo_2013_076

Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression (598 — 604)

Q. GUO, X. X. NAN, J. R. YANG, L. YI, B. L. LIANG, Y. B. WEI, N. ZHU, S. B. HU, H. ZHANG, Y. LUO, Y. F. XU

DOI: 10.4149/neo_2013_077

Overexpression of platelet-derived growth factor-B increases the growth, invasion, and angiogenesis of gastric carcinoma cells through protein kinase B (605 — 613)

Y. GUO, J. YIN, Z. WANG, L. ZHA

DOI: 10.4149/neo_2013_078

Radiosensitization of breast cancer cells by TRAIL-endostatin-targeting gene therapy (613 — 619)

Y. B. LI, C. X. GUO, Z. C. WANG, L. H. DONG, F. GUAN, Y. LIU, H. F. WANG, Z. W. SUN, S. L. GONG

DOI: 10.4149/neo_2013_079

Cell-cycle arrest at G2/M and proliferation inhibition by adenovirus-expressed mitofusin-2 gene in human colorectal cancer cell lines (620 — 626)

X. CHENG, D. ZHOU, J. WEI, J. LIN

DOI: 10.4149/neo_2013_080

Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line (627 — 634)

J. DURAJ, M. PASTOREK, J. VITKOVSKA, D. CHOLUJOVA, P. GRONESOVA, L. HUNAKOVA, J. SEDLAK

DOI: 10.4149/neo_2013_081

Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer (635 — 646)

I. ZMETAKOVA, L. DANIHEL, B. SMOLKOVA, M. MEGO, V. KAJABOVA, T. KRIVULCIK, I. RUSNAK, B. RYCHLY, D. DANIS, V. REPISKA, P. BLASKO, M. KARABA, J. BENCA, J. PECHAN, I. FRIDRICHOVA

DOI: 10.4149/neo_2013_082

The use of electrical impedance tomography to the differential diagnosis of pathological mammographic/sonographic findings (647 — 654)

O. RANETA, V. BELLA, L. BELLOVA, E. ZAMECNIKOVA

DOI: 10.4149/neo_2013_083

Clustering of mutations in the 5’ tertile of the NF1 gene in Slovakia patients with optic pathway glioma (655 — 665)

A. BOLCEKOVA, M. NEMETHOVA, A. ZATKOVA, K. HLINKOVA, S. POZGAYOVA, A. HLAVATA, L. KADASI, D. DUROVCIKOVA, A. GERINEC, K. HUSAKOVA, Z. PAVLOVICOVA, M. HOLOBRADA, L. KOVACS, D. ILENCIKOVA

DOI: 10.4149/neo_2013_084

Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: Its correlation with FLT3 (666 — 675)

S. V. MEHTA, S. N. SHUKLA, H. H. VORA

DOI: 10.4149/neo_2013_085

Erlotinib in the treatment of advanced squamous cell NSCLC (676 — 682)

O. FIALA, M. PESEK, J. FINEK, J. KREJCI, L. HAVEL, M. HRNCIARIK, F. SALAJKA, Z. BORTLICEK, L. BENESOVA, M. MINARIK

DOI: 10.4149/neo_2013_086

The predictive value of semaphorins 3 expression in biopsies for biochemical recurrence of patients with low- and intermediate-risk prostate cancer (683 — 689)

K. LI, M. K. CHEN, L. Y. LI, M. H. LU, CH. K. SHAO, Z. L. SU, D. HE, J. PANG, X. GAO

DOI: 10.4149/neo_2013_087

Endotelial activation and flow-mediated vasodilation in young patients with breast cancer (690 — 697)

P. TESAROVA, M. KALOUSOVA, T. ZIMA, M. SUCHANEK, I. MALIKOVA, J. KVASNICKA, D. DUSKOVA, V. TESAR, J. VACHEK, Z. KRUPICKOVA-KASALOVA, J. MALIK

DOI: 10.4149/neo_2013_088

A Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder (698 — 705)

Y. YUAN,, Z. L. YANG, Q. ZOU,, J. H. LI, D. Q. LI, L. F. LIANG, G. X. ZENG, S. L. CHEN

DOI: 10.4149/neo_2013_089

Recent patterns in cutaneous melanoma descriptive epidemiology in the Slovak Republic (706 — 713)

M. ONDRUSOVA, B. MRINAKOVA, D. ONDRUS, K. POLAKOVA, S. DURDIK

DOI: 10.4149/neo_2013_090